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The Korean venous thromboembolism (VTE) registry, which was initiated by the 
Working Parties of Korean Society on Thrombosis and Hemostasis, and the Kore-
an Society of Hematology, is a web-based multicenter registry (http://kdvt.chamc.
co.kr) for recruiting consecutive VTE patients. The aim of the registry is to pro-
spectively collect data on the epidemiology and clinical outcomes of VTE from a 
large, unselected cohort of patients, and to provide data on the true incidence and 
management of VTE in the real-world. By the end of 2007, the starting year of the 
registry, 840 patients were registered. By the end of 2008, 1,121 were registered, 
with 1,289 by the end of 2009, and 1,463 by April 2010 from 11 hospitals. The 
first report on the epidemiologic characteristics of 596 consecutive VTE patients 
was released in October 2007.
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VTE IN KOREA
   
Venous thromboembolism (VTE) is the third most common cardiovascular dis-
ease after myocardial infarction and stroke.1 More than 600,000 cases of VTE oc-
cur annually in the United States of America, and 50,000 deaths due to pulmonary 
embolism.2 The annual mortality from VTE surpasses the sum of the mortalities 
from breast cancer, prostate cancer, AIDS and traffic accidents in Europe.3 The in-
cidence of VTE in Koreans has been generally found to be lower than Caucasian, 
but it appears to be rapidly increasing, possibly because of the widespread adop-
tion of a westernized life style4 and increased awareness of VTE among physicians 
and the community. Therefore, it is to raise awareness of this health issue to reduce 
mortality from VTE. 
VTE REGISTRY IN KOREA AND ITS 
CURRENT ACTIVITIES
   
In order to promote the study on the epidemiology, clinical and basic research of 
VTE in Koreans, the Korean Society of Hematology (KSH) and Korean Society Korean VTE Registry
Yonsei Med J   http://www.eymj.org   Volume 52   Number 4   July 2011 559
(p=0.014) (Table 1). Using the registry, clinical epidemio-
logic research on metabolic syndrome4 and cancer patients5 
were carried out. The activation of the registration has en-
abled participating clinicians to manage their VTE patients 
according to the international standard of care on VTE, and 
resulted in qualitative improvement in diagnosis and treat-
ment of VTE. These include rapid and accurate diagnosis 
by early use of compression ultrasonography (CUS) and 
pulmonary CT angiogram, home treatment using low mo-
lecular weight heparin (LMWH), careful use of thrombolysis 
or IVC filter insertion, use of dosing nomogram for VKA-, 
and adoption of the updated ACCP guidelines, among other 
things. The registry also enables stratification of risk groups 
on diagnostic timing. Increased detection of VTE patients 
by the activation of the registry made it possible to carry 
out large clinical trials. Since March 2008, international 
clinical trials such as RECOVER-II (NCT00680186), RES-
ONATE (NCT00329238), MAGELLAN (NCT00571649), 
and HOKUSAI (NCT00680186) have been carried out in 
Korea and the number is increasing. Clinical studies using 
therapeutic or preventive devices or diagnostic reagents 
will also be applicable soon. 
  
ACTIVITIES OF VTE REGISTRY  
IN WESTERN COUNTRIES 
　　　
Many registries and databases several of which enroll VTE 
patients exclusively, such as Worchester DVT Study,2 Roch-
estrer Epidemiology Project,6 Brigham and Women’s hospi-
tal DVT Registry,7 California Patient Discharge Data,8 Mal-
mo DVT Study,9 Nord-Trondelag VTE Study,1 Study of 
Men Born in 1913,10 Swedish Inpatient Registry,11 Bretagne 
on Thrombosis and Hemostasis (KSTH) organized the work-
ing party on VTE in October 2005 and 2006, respectively. 
Because the core members of both working parties are basi-
cally similar, the working party was termed “The KSH/
KSTH-Deep Vein Thrombosis Working Party (KSH/KSTH-
DVTWP)”. Since the registry includes pulmonary embolism 
(PE) in addition to DVT, its name was changed to “The 
KSH/KSTH VTE Working Party (KSH/KSTH-VTEWP)” 
in 2009. It is a web-based, multicenter registry (http://kdvt.
chamc.co.kr) recruiting consecutive VTE patients from 11 
teaching hospitals.4 Patient enrollment began since January 1, 
2007, and the registry is the largest registry on VTE in Korea. 
The aim of the registry is to prospectively collect data on the 
epidemiology and clinical outcomes of VTE from a large un-
selected cohort of patients and to provide the data on the true 
incidence and management of VTE in the real-world. 
By the end of the first year, 840 patients with VTE were 
registered from nine initial university hospitals. A total of 
1,121 were registered by the end of 2008, 1,289 by the end of 
2009, and 1,463 by April 2010 from 11 hospitals. The first 
report on the epidemiologic characteristics of 596 consecu-
tive VTE patients was released in October 2007. The pro-
portions of patient over 50 years old was 76% among the 
596 VTE patients. VTE developed more frequently in we-
men than men. Major risk factors for VTE were old age, 
cancer, immobilization, surgery, severe medical disease, 
stroke, and trauma. In 28% (158/596) of the patients, VTE 
was idiopathic. Cancer was associated with VTE in 24% 
(134/596) and cancer was detected after diagnosis of VTE 
in 4% (24/596). Cancer-associated DVT frequently oc-
curred was developed in an atypical location more frequently 
than DVT without cancer (p=0.0465). PE was more fre-
quently associated with idiopathic VTE than secondary VTE 
Table 1. Characteristics of Korean Patients with Idiopathic Venous Thromboembolism
Secondary VTE (n=401)  Idiopathic VTE (n=158) p  value
Mean age   61   59 0.08
M : F 170 : 231 71 : 87 0.65
Types of VTE 0.01
    DVT 181 59
    DVT+PE 133 46
    PE   87 53
Sites of DVT  0.01
    Left limb 148 67
    Right limb   95 20
    Both limb   30   5
    Abdominal cavity   19   3
    Upper limb     4   1
VTE, venous thromboembolism; DVT, deep vein thrombosis; PE, pulmonary embolism.  Doyeun Oh
Yonsei Med J   http://www.eymj.org   Volume 52   Number 4   July 2011 560
ed studies will be necessary for vitalizing our registry. Be-
cause the ultimate goal of VTE study is the improvement in 
the quality of management, we hope that our registry will 
be applicable in the development of new drugs and diag-
nostic reagents or devices.   
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